Cargando…
Current and Future Treatments in the Fight against Non-Alcoholic Fatty Liver Disease
Obesity is recognised as a risk factor for many types of cancers, in particular hepatocellular carcinoma (HCC). A critical factor in the development of HCC from non-alcoholic fatty liver disease (NAFLD) is the presence of non-alcoholic steatohepatitis (NASH). Therapies aimed at NASH to reduce the ri...
Autores principales: | Smeuninx, Benoit, Boslem, Ebru, Febbraio, Mark A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407591/ https://www.ncbi.nlm.nih.gov/pubmed/32605253 http://dx.doi.org/10.3390/cancers12071714 |
Ejemplares similares
-
Non-alcoholic fatty liver disease: leading the fight in primary care
por: Theodoreson, Mark D, et al.
Publicado: (2022) -
Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: Current and Potential Future Treatments
por: Sasaki, Akira, et al.
Publicado: (2014) -
Non-alcoholic fatty liver diseases: current challenges and future directions
por: Roeb, Elke
Publicado: (2021) -
Current treatment of non‐alcoholic fatty liver disease
por: Paternostro, Rafael, et al.
Publicado: (2022) -
Non-Alcoholic Fatty Liver Disease: Current Perspectives and Future Direction in Disease pathogenesis, Treatment and Diagnosis
por: Athinarayanan, Shaminie, et al.
Publicado: (2012)